22nd Century Price to Free Cash Flow Ratio 2011-2024 | XXII
Historical price to free cash flow ratio values for 22nd Century (XXII) since 2011.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| 22nd Century Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2025-01-31 |
4.11 |
|
0.00 |
| 2024-09-30 |
0.22 |
$-261.71 |
0.00 |
| 2024-06-30 |
0.75 |
$-193.64 |
0.00 |
| 2024-03-31 |
1.92 |
$-3,224.15 |
0.00 |
| 2023-12-31 |
2.98 |
$-6,196.99 |
0.00 |
| 2023-09-30 |
15.64 |
$-9,854.74 |
0.00 |
| 2023-06-30 |
91.85 |
$-11,644.12 |
0.00 |
| 2023-03-31 |
184.56 |
$-10,685.75 |
0.00 |
| 2022-12-31 |
220.92 |
$-9,243.68 |
0.00 |
| 2022-09-30 |
222.55 |
$-6,598.36 |
0.00 |
| 2022-06-30 |
511.20 |
$-5,973.89 |
0.00 |
| 2022-03-31 |
556.80 |
$-5,619.24 |
0.00 |
| 2021-12-31 |
741.60 |
$-4,894.14 |
0.00 |
| 2021-09-30 |
710.40 |
$-4,425.02 |
0.00 |
| 2021-06-30 |
1111.20 |
$-3,621.34 |
0.00 |
| 2021-03-31 |
789.60 |
$-3,468.25 |
0.00 |
| 2020-12-31 |
528.00 |
$-3,659.09 |
0.00 |
| 2020-09-30 |
153.79 |
$-3,694.76 |
0.00 |
| 2020-06-30 |
183.46 |
$-4,203.71 |
0.00 |
| 2020-03-31 |
180.00 |
$-3,734.97 |
0.00 |
| 2019-12-31 |
264.00 |
$-3,849.53 |
0.00 |
| 2019-09-30 |
542.40 |
$-4,978.17 |
0.00 |
| 2019-06-30 |
501.60 |
$-4,838.92 |
0.00 |
| 2019-03-31 |
410.40 |
$-5,230.85 |
0.00 |
| 2018-12-31 |
597.60 |
$-4,770.94 |
0.00 |
| 2018-09-30 |
674.40 |
$-3,755.10 |
0.00 |
| 2018-06-30 |
590.40 |
$-4,003.16 |
0.00 |
| 2018-03-31 |
564.00 |
$-4,016.52 |
0.00 |
| 2017-12-31 |
672.00 |
$-4,237.94 |
0.00 |
| 2017-09-30 |
664.80 |
$-4,210.09 |
0.00 |
| 2017-06-30 |
420.00 |
$-4,074.99 |
0.00 |
| 2017-03-31 |
283.20 |
$-3,836.30 |
0.00 |
| 2016-12-31 |
261.60 |
$-4,094.43 |
0.00 |
| 2016-09-30 |
348.00 |
$-4,533.34 |
0.00 |
| 2016-06-30 |
194.90 |
$-4,265.18 |
0.00 |
| 2016-03-31 |
187.92 |
$-4,727.19 |
0.00 |
| 2015-12-31 |
336.00 |
$-3,500.88 |
0.00 |
| 2015-09-30 |
201.60 |
$-2,237.08 |
0.00 |
| 2015-06-30 |
225.60 |
$-1,756.07 |
0.00 |
| 2015-03-31 |
206.40 |
$-0.13 |
0.00 |
| 2014-12-31 |
396.00 |
$-0.10 |
0.00 |
| 2014-09-30 |
604.80 |
$0.01 |
0.00 |
| 2014-06-30 |
736.80 |
$0.02 |
40707.18 |
| 2014-03-31 |
780.00 |
$0.03 |
24605.68 |
| 2013-12-31 |
513.60 |
$0.01 |
0.00 |
| 2013-09-30 |
309.60 |
$-0.07 |
0.00 |
| 2013-06-30 |
170.40 |
$-0.06 |
0.00 |
| 2013-03-31 |
211.20 |
$-0.08 |
0.00 |
| 2012-12-31 |
180.00 |
$-0.06 |
0.00 |
| 2012-09-30 |
67.20 |
$-0.08 |
0.00 |
| 2012-06-30 |
84.00 |
$-0.08 |
0.00 |
| 2012-03-31 |
148.80 |
$-0.07 |
0.00 |
| 2011-12-31 |
100.80 |
$-0.13 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.002B |
$0.032B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
